Clinical Trial Update: A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC) [Phase 1]

View source ↗

Summary

Phase 1 study investigating CEA-PRIT 2.0 in metastatic colorectal cancer by Hoffmann-La Roche is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CEA-PRIT 2.0

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Metastatic Colorectal Cancer | Phase 1 | Status: RECRUITING